Products

Naptumomab estafenatox (TAB-118-F(E))

Recombinant antibody Fragment Fab to 5T4. Naptumomab estafenatox (ABR-217620) is a drug being developed for the treatment of various types of cancer like non-small cell lung carcinoma and renal cell carcinoma.      

Specifications
Immunogen
The details of the immunogen for this antibody are not available.
Host
Mouse
Derivation
Mouse
Type
Fab - G1 - kappa
Specificity
Tested positive against native human antigen.
Species Reactivity
Human
Applications
Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.
CAS NO.
676258-98-3
Generic Name
Naptumomab estafenatox
UNII
93T929W6LC
M.W.
73.5 kDa
Related Disease
Renal cell carcinoma (RCC)
Target
Alternative Names
Naptumomab estafenatox; 676258-98-3; ABR-217620; ABR-217620; TPBG; trophoblast glycoprotein; 5T4; 5T4 AG
Entrez Gene ID
7162
UniProt ID
Q13641

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-871-5806    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2017 Creative-Biolabs All Rights Reserved